Stress ulcer prophylaxis: The prevention of gastrointestinal bleeding and the development of nosocomial infections in critically ill patients

Journal of Pharmacy Practice

Volumn 11, Issue 6, 1998, Pages 418-436

  Reilly, Joseph ^a,b   Fennerty, M Brian ^c  

^a LONG ISLAND UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ALUMINUM HYDROXIDE; ANTACID AGENT; CALCIUM HYDROXIDE; CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MAGNESIUM HYDROXIDE; MISOPROSTOL; NIZATIDINE; OMEPRAZOLE; PIRENZEPINE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; SUCRALFATE;

ALKALINIZATION; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL TRANSLOCATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; DRUG COST; ENTERIC FEEDING; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW; RISK FACTOR; SIDE EFFECT; STOMACH JUICE; STOMACH PH; STRESS ULCER;

EID: 0032449126     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1177/089719009801100603     Document Type: Review

References (96)

1. Shuman RB, Schuster DP, Zuckerman GR. 1987. "Prophylactic therapy for stress ulcer bleeding: a reappraisal," Ann Intern Med, 106(4):562-7.
2. Peura DA, Johnson LF. 1985. "Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit," Ann Intern Med, 103:173-7.
3. Goldin GF, Peura DA. 1996. "Stress-related mucosal damage," Gastro Endosc Clin N Amer, 6(3)505-26.
4. Cook DJ, Fuller HD, Guyatt GH, et al. 1994. "Risk factors for gastrointestinal bleeding in critically ill patients," NEJM, 330(6):377-81.
5. Ben-Menachem T, Fogel R, Patel RV, et al. 1994. "Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit: a randomized, controlled, single-blind study," Ann Intern Med, 121(8):568-75.
6. Fagon JY, Chastre J, Hance AJ, et al. 1993. "Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay," Am J Med, 94: 281-8.
7. Langer M, Cigada M, Mandelli M, Mosconi P, Tognomi G. 1987. "Early-onset pneumonia: a multicenter study in intensive care units," Intensive Care Med, 13:342-6.
8. Lowy FD, Carlisle PS, Adams A, Feiner C. 1987. "The incidence of nosocomial pneumonia following urgent endotracheal intubation," Infect Control, 8:245-8.
9. Zinner MJ, Turtinen L, Gurll NJ. 1975. "The role of acid and ischemia in production of stress ulcers during canine hemorrhagic shock," Surgery, 77:807.
10. Arvidsson S, Haglund V. 1984. "Acute gastric ulceration in septic shock: an experimental model," Scand J. Gastroenterol, 105:46.
11. Goodman AA, Osborne MP. 1972. "An experimental model and clinical definition of stress ulceration," Surg Gynecol Obstet, 134(4):563.
12. Levine BA. 1987. "Pathophysiology and mechanisms of stress ulcer injury," Pharmacotherapy, 7(Suppl 6 Pt 2):90s-4s.
13. Lucas CE, Sugawa C, Riddle J, et al. 1971. "Natural history and surgical dilemma of stress gastric bleeding," Arch Surg, 102:266-73.
14. Tryba M. 1990. "Stress bleeding prophylaxis with sucralfate: pathophysiologic basis and clinical use," Scand J Gastroenterol, 25(Suppl 173):22.
15. Stannard VA, Hutchinson A, Morris DL, Byrne A. 1988. "Gastric exocrine 'failure' in critically ill patients. Incidence and associated features," Br Med J, 296:155-6.
16. Miller TA. 1987. "Mechanisms of stress-related mucosal damage," Am J Med, 83(Suppl 6A):8-14.
17. Parks DA, Bulkley DB, Granger DN. 1983. "Role of oxygen-derived free radicals in digestive tract diseases," Surgery, 94:415-22.
18. Itoh M, Guth PH. 1986. "Role of oxygen-derived free radicals in hemorrhagic shock-induced gastric lesions in the cat stomach," Gastroenterology, 90:362.
19. Duckworth C, Peura DA. 1995. "H. pylori infection and GI disease: what critical care physicians need to know," J Crit Ill, 10:105-17.
20. Zuckerman GR, Cort D, Shuman RB. 1988. "Stress ulcer syndrome," J Intensive Care Med, 3(1):21.
21. Fisher RL, Pipkin GA, Wood JR. 1995. "Stress-related mucosal disease," Crit Care Clin, 11:323-45.
22. Tryba M, Cook D. 1997. "Current guidelines on stress ulcer prophylaxis," Drugs, 54(4):581-96.
23. Hatton J, Lu WY, Rhoney DH, et al. 1996. "A step-wise protocol for stress ulcer prophylaxis in the neurosurgical intensive care unit," Surg Neurol, 46:493-9.
24. Hirschowitz BI. 1984. "Pepsinogen," Postgrad Med J, 60:743-50.
25. Tryba M. 1991. "Stress bleeding prophylaxis 1990 - a meta analysis," Clin J Gastroenterol, 13(Suppl2):44-55.
26. Fiorucci S, Clausi GC, Farinelli M, et al. 1989. "Intragastric pH monitoring during antisecretory therapy in patients with gastrointestinal bleeding," Am J Gastroenterol, 84(11):1416-20.
27. Ballesteros MA, Hogdon DL, Koss MA, Isenberg JI. 1990. "Bolus or intravenous infusion of ranitidine. Effects on gastric pH and acid secretion: a comparison of relative cost and efficacy," Ann Intern Med, 112:334-9.
28. Szabo S, Hollander D. 1989. "Pathway of gastrointestinal protection and repair: mechanisms of sucralfate," Am J Med, 86(Suppl 6A):23-31.
29. Frydman GM, Penney AG, Malcontenti C, et al. 1991. "Inability of cytoprotection to occur during a period of gastric ischemia," Dig Dis Sci, 36(10): 1353-60.
30. Laudanno OM, Bedini OA, Cesolari JA, et al. 1992. "Sucralphate in the prevention of acute gastric lesions induced by ischemia-reperfusion," Ital J Gastroenterol, 24(7):380-2.
31. Tryba M, Kurz-Muller K, Donner B. 1994. "Plasma aluminum concentrations in long term mechanically ventilated patients receiving stress ulcer prophylaxis with sucralfate," Crit Care Med, 22(11):1769-74.
32. Sachs G. 1997. "Proton pump inhibitors and acid-related diseases," Pharmacotherapy, 17(1): 22-37.
33. Garnett WR. 1993. "Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease," Am J. Hosp Pharm, 50(Suppl 1):11-18.
34. Phillips JO, Metzler MH, Palmieri MTL, et al. 1996. "A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage," Crit Care Med, 24(11):1793-800.
35. Sharma VK, Vasudeva R, Howden, CW. 1998. "Simplified lansoprazole suspension (SLS): a proton pump inhibitor (PPI) in a liquid formulation that works," Am J Gastroenterol, 93:A1647.
36. 2-receptor antagonists," Dig Dis Sci, 8:976-83.
37. 2-receptor antagonists," Aliment Pharmacol Ther, 4(Suppl 1):15-27.
38. 2-blockade," Aliment Pharmacol Ther, 4(Suppl 1):47-63.
39. Nwokolo CU, Smith JTL, Gavey C, et al. 1990. "Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine," Aliment Pharmacol Ther, 4(Suppl 1):29-45.
40. Merki HS, Wilder-Smith CH. 1994. "Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?" Gastroenterol, 106:60-4.
41. Levy MJ, DiPalma JA. 1996. "Stress ulcer prophylaxis may not be for everyone," Curr Opin Crit Care, 2:129-33.
42. Chung-Ja MC, Randall HT. 1981. "Osmolality of liquid and defined formula diets: the effects of hydrolysis by pancreatic enzymes," JPEN, 5:7-10.
43. Pingleton SK, Hadizma S. 1983. "Enterai alimentation and gastrointestinal bleeding in mechanically ventilated patients," Crit Care Med, 11:13-6.
44. Skillman JJ, Libson A, Long PC, et al. 1984. "15(R)-15-methyl prostaglandin E2 does not prevent gastrointestinal bleeding in seriously ill patients," Am J Surg, 147:451-5.
45. van Essen HA, van Blankenstein M, Wilson JH, et al. 1985. "Intragastric prostaglandin E2 and the prevention of gastrointestinal hemorrhage in ICU patients," Crit Care Med, 13:957-60.
46. Zinner MJ, Rypins EB, Martin LR, et al. 1989. "Misoprostol versus antacid titration for preventing stress ulcers in postoperative surgical ICU patients," Ann Surg, 210(5):590-5.
47. Martin LF, Booth FV, Reines HD, et al. 1992. "Stress ulcer and organ failure in intubated patients in surgical intensive care units," Ann Surg, 215:332-7.
48. Szabo S, Trier JS, Frankel PW. 1981. "Sulfhydryl compounds may mediate gastric cytoprotection," Science, 214:200-2.
49. Parmar NS, Tariq M, Ageel AM. 1988. "Gastric anti-ulcer and cytoprotective effect of selenium in rats," Toxicol Appl Pharmacol, 91:122-30.
50. Al-Moutairy AR, Tariq M. 1996. "Effect of vitamin E and selenium on hypothermic restraint stress and chemically-induced ulcers," Dig Dis Sci, 41(6):1165-71.
51. Ekman T, Bagge U, Risberg B, Soussi B. 1995. "Ascorbate preserves gastric mucosal metabolism and microcirculation after hemorrhagic shock and retransfusion in rats," Eur Surg Res, 27:39-48.
52. Granger DN, Harnandez LA, Grisham MB. 1986. "Reactive oxygen metabolites: mediators of cell injury in the digestive system," Viewpoints Dig Dis, 18:13-16.
53. Knodell RG, Rosenthal LE. 1987. "Stress-related mucosal damage: critical evaluation of potential new therapeutic agents," Pharmacotherapy, 7:104s-109s.
54. Stuart RC, Gorey TF, Kay E, et al. 1989. "Acute gastric stress ulceration: prophylaxis with allopurinol," J R Coll Surg Edinb, 34: 321-5.
55. Salim AS. 1991. "Protection against stress-induced gastric mucosal injury by free radical scavengers," Intensive Care Med, 17:455-60.
56. Itoh M, Guth PH. 1985. "Role of oxygen-derived free radicals in hemorrhagic shock-induced gastric lesions in rats," Gastroenterology, 88:1162-7.
57. Cook DJ, Reeve BK, Guyatt GH, et al. 1996. "Stress ulcer prophylaxis in critically ill patients," JAMA, 275(4):308-14.
58. Cook D, Guyatt G, Marshall J, et al. 1998. "A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation," NEJM, 338(12):791-7.
59. Driks MR, Craven DE, Celli BR, et al. 1987. "Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: the role of gastric colonization," NEJM, 317:1376-82.
60. Tryba M. 1987. "Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients: sucralfate versus antacids," Am J Med, 83:117.
61. Gross PA, Neu HC, Aswapokee P, et al. 1980. "Deaths from nosocomial infection: experience in a university hospital and a community hospital," Am J Med, 68:219-23.
62. Craven DE, Kunches LM, Kilinsky V, et al. 1986. "Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation," Am Rev Resp Dis, 133:792-6.
63. Reed PJ, Smith PL, Hainkes K, House FR, Walters CL. 1980. "Gastric juice N-nitrosamines in health and gastrointestinal disease," Lancet, 2:550.
64. Du Moulin GC, Paterson DG, Hedley-White J, Libson A. 1982. "Aspiration of gastric bacteria in antacid treated patients: a frequent cause of postoperative colonisation of the airway," Lancet, 1:242-5.
65. Donowitz LG, Page MC, Mileur BL, Guenthner SH. 1986. "Alteration of normal gastric flora in critical care patients receiving antacid or cimetidine therapy," Infect Control, 7:23-6.
66. Daschner F, Kappstein I, Engels I, et al. 1988. "Stress ulcer prophylaxis and ventilation pneumonia: protection by antibacterial cytoprotective agents?" Infect Control Hosp Epidemiol, 9:59-65.
67. Ruddell WS, Axon AT, Findlay JM, et al. 1980. "Effect of cimetidine on the gastric bacterial flora," Lancet, 1:612-4.
68. Stockbrugger RW, Cotton PB, Eugenides N, et al. 1982. "Intragastric nitrates, nitrosamines and bacterial overgrowth during cimetidine treatment," Gut, 23:1048-54.
69. Lehot JJ, Deleat-Besson R, Bastien O, et al. 1990. "Should we inhibit gastric acid secretion before cardiac surgery," Anesth Analg, 70: 185-90.
70. Hillman KM, Riordan T, O'Farrel SM, et al. 1982. "Colonization of the gastric contents in critically ill patients," Crit Care Med, 10: 444-7.
71. Cameron JL, Reynolds J. Zuidema GD. 1973. "Aspiration in patients with tracheostomies," Surg Gynecol Obstet, 136:68-70.
72. Craven DE, Daschner FD. 1989. "Nosocomial pneumonia in the intubated patient: role of gastric colonization," Eur J Clin Microbiol Infect Dis, 8:40-50.
73. Deitch EA, Wintertin J, Li M, Berg R. 1987. "The gut as a portal of entry for bacteremia -role of protein malnutrition," Ann Surg, 205:681-92.
74. Gray JDA, Shiner M. 1977. "Influence of gastric pH on gastric and jejunal flora," Gut, 8:574-81.
75. Gianotti L, Alexander JW, Fukushima R, Pyles T. 1993. "Reduction of bacterial translocation with oral fibroblast growth factor and sucralfate," Am J. Surg, 165:195-201.
76. Jacobs S, Chang RWS, Lee B, Bartlett F. 1990. "Continuous enteral feeding: a major cause of pneumonia among ventilated intensive care unit patients," J Par Ent Nutr, 14:353-6.
77. Feistauer SM, Laggner AM, Makristathis A, Georgopoulos A. 1991. "Influence of stress ulcer prophylaxis on translocation of bacteria from the intestinal tract in rats" [Abstract], Circ Shock, 34:25.
78. Tryba M, Cook DJ. 1995. "Gastric alkalinization, pneumonia, and systemic infections: the controversy," Scand J Gastroenterol, 30(Suppl):210:53-9.
79. Meijer K, Van Saene HFK, Hill JC. 1990. "Infection control in patients undergoing mechanical ventilation: traditional approach versus a new development - selective decontamination of the digestive tract," Heart Lung, 19:11-20.
80. Gomez EC, Markowsky SJ, Rotschafner JC. 1992. "Selective decontamination of the digestive tract in intensive care patients: review and commentary," Ann Pharmacother, 26:963-76.
81. Ortiz JE, Sottile FD, Sigel P, et al. 1998. "Gastric colonization as a consequence of stress ulcer prophylaxis: a prospective, randomized trial," Pharmacotherapy, 18(3):486-91.
82. Tryba M. 1991. "The gastropulmonary route of infection - fact or fiction?" Am J Med, 91(Suppl 2A):135s-146s.
83. 2-receptor antagonists in the pathogenesis of nosocomial pneumonia in mechanically ventilated patients," Pharmacotherapy, 18(4):808-15.
84. Prod'hom G, Leuenberger P, Koerfer J, et al. 1994. "Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer," Ann Intern Med, 120:653-62.
85. Eddleston JM, Vohra A, Scott P, et al. 1991. "A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate-or ranitidine-treated intensive care unit patients," Crit Care Med, 19:1491-6.
86. Winter R, MacGowan AP, Speller DC, et al. 1989. "Gastric pH and colonisation in sucralfate treated patients" [Letter], Intensive Care Med, 15:216-7.
87. Stannard VA, Hutchinson A, Morris DL, Byrne A. 1988. "Gastric exocrine failure in critically ill patients: incidence and associated features," Br Med J (Clin Res Ed), 296:155-6.
88. Tryba M, Mantey-Stiers F. 1987. "The antibacterial activity of sucralfate in human gastric juice," Am J Med, 83:125-7.
89. Tryba M. 1989. "Side effects of stress bleeding prophylaxis," Am J Med, 86(Suppl 6A): 85-93.
90. McCarthy DM. 1991. "Sucralfate," NEJM, 325(14):1017-25.
91. Eddleston JM, Pearson RC, Holland J, et al. 1994. "Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo," Crit Care Meet, 22:1949-54.
92. Cook DJ, Walter SD, Cook RJ, et al. 1998. "Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients," Ann Intern Med, 129:433-40.
93. Reusser P, Zimmerli W, Scheidegger D, et al. 1990. "Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: current incidence and effect of acid-reducing prophylaxis," Crit Care Med, 18:270-4.
94. Schuster DP, Rowley H, Feinstein S, et al. 1984. "Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit," Am J Med, 76:623-30.
95. Ben-Menachem T, McCarthy BD, Fogel R, et al. 1996. "Prophylaxis for stress-related gastrointestinal hemorrhage: A cost effectiveness analysis," Crit Care Med, 24(2):338-45.
96. Richter J, Huse D, Thompson D, et al. 1989. "Sucralfate suspension versus acid neutralization as stress-ulcer prophylaxis during mechanical ventilation: economic implications for critical care medicine," Am J Gastroenterol, 84:1168.